NYSE:STE - STERIS Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$104.49 -0.19 (-0.18 %)
(As of 05/25/2018 03:11 AM ET)
Previous Close$104.49
Today's Range$104.12 - $105.38
52-Week Range$76.47 - $105.38
Volume295,292 shs
Average Volume375,556 shs
Market Capitalization$8.83 billion
P/E Ratio25.18
Dividend Yield1.19%
Beta1.12

About STERIS (NYSE:STE)

STERIS logoSTERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products. In addition, this segment offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The company's Healthcare Specialty Services segment provides solutions, and outsourced and managed services for acute care hospitals and other healthcare settings, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting services. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The company's Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 50 facilities. The company was founded in 1985 and is headquartered in Leicester, the United Kingdom.

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:STE
CUSIP85915210
Phone44-13-3238-7100

Debt

Debt-to-Equity Ratio0.41
Current Ratio2.48
Quick Ratio1.97

Price-To-Earnings

Trailing P/E Ratio25.18
Forward P/E Ratio22.18
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.62 billion
Price / Sales3.38
Cash Flow$5.4140 per share
Price / Cash19.30
Book Value$37.92 per share
Price / Book2.76

Profitability

EPS (Most Recent Fiscal Year)$4.15
Net Income$290.91 million
Net Margins11.10%
Return on Equity11.55%
Return on Assets6.93%

Miscellaneous

Employees12,000
Outstanding Shares84,850,000

STERIS (NYSE:STE) Frequently Asked Questions

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Friday, May 11th. Shareholders of record on Friday, June 8th will be paid a dividend of $0.31 per share on Thursday, June 28th. This represents a $1.24 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend is Thursday, June 7th. View STERIS's Dividend History.

How were STERIS's earnings last quarter?

STERIS (NYSE:STE) released its quarterly earnings data on Wednesday, May, 9th. The medical equipment provider reported $1.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.22 by $0.02. The medical equipment provider had revenue of $716 million for the quarter, compared to the consensus estimate of $703.37 million. STERIS had a net margin of 11.10% and a return on equity of 11.55%. The firm's revenue was up 5.1% on a year-over-year basis. During the same period last year, the company posted $1.11 EPS. View STERIS's Earnings History.

When is STERIS's next earnings date?

STERIS is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for STERIS.

What guidance has STERIS issued on next quarter's earnings?

STERIS updated its FY19 earnings guidance on Wednesday, May, 9th. The company provided earnings per share guidance of $4.63-$4.75 for the period, compared to the Thomson Reuters consensus estimate of $4.69.

What price target have analysts set for STE?

5 Wall Street analysts have issued 12-month target prices for STERIS's shares. Their predictions range from $16.00 to $103.00. On average, they expect STERIS's stock price to reach $80.25 in the next year. View Analyst Ratings for STERIS.

Who are some of STERIS's key competitors?

Who are STERIS's key executives?

STERIS's management team includes the folowing people:
  • Mr. Walter M. Rosebrough Jr., Pres, CEO & Director (Age 64)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Treasurer (Age 49)
  • Mr. John Adam Zangerle, VP, Gen. Counsel & Sec. (Age 51)
  • Mr. Daniel A. Carestio, Sr. VP of Applied Sterilization Technologies and Life Sciences (Age 45)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 48)

Has STERIS been receiving favorable news coverage?

Headlines about STE stock have trended somewhat positive on Friday, according to Accern. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. STERIS earned a media sentiment score of 0.04 on Accern's scale. They also gave press coverage about the medical equipment provider an impact score of 46.55 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are STERIS's major shareholders?

STERIS's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.81%), Massachusetts Financial Services Co. MA (2.55%), Westfield Capital Management Co. LP (1.95%), Principal Financial Group Inc. (1.93%), Principal Financial Group Inc. (1.93%) and Fisher Asset Management LLC (1.71%). Company insiders that own STERIS stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for STERIS.

Which major investors are selling STERIS stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Principal Financial Group Inc., Champlain Investment Partners LLC, Envestnet Asset Management Inc., Fisher Asset Management LLC, Westfield Capital Management Co. LP, Daiwa Securities Group Inc. and Public Employees Retirement Association of Colorado. Company insiders that have sold STERIS company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for STERIS.

Which major investors are buying STERIS stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Robeco Institutional Asset Management B.V., BlackRock Inc., Massachusetts Financial Services Co. MA, Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN and Chicago Equity Partners LLC. View Insider Buying and Selling for STERIS.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $104.49.

How big of a company is STERIS?

STERIS has a market capitalization of $8.83 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. STERIS employs 12,000 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]


MarketBeat Community Rating for STERIS (STE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  235 (Vote Underperform)
Total Votes:  394
MarketBeat's community ratings are surveys of what our community members think about STERIS and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

STERIS (NYSE:STE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for STERIS in the last 12 months. Their average twelve-month price target is $80.25, suggesting that the stock has a possible downside of 23.20%. The high price target for STE is $103.00 and the low price target for STE is $16.00. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.602.60
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $80.25$80.25$80.25$72.00
Price Target Upside: 23.20% downside4.68% downside4.68% downside18.34% downside

STERIS (NYSE:STE) Consensus Price Target History

Price Target History for STERIS (NYSE:STE)

STERIS (NYSE:STE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018KeyCorpReiterated RatingBuy$103.00MediumView Rating Details
2/8/2018Northcoast ResearchSet Price TargetBuy$102.00MediumView Rating Details
1/3/2018Raymond JamesReiterated RatingOutperform ➝ Market Perform$100.00HighView Rating Details
11/9/2017TD SecuritiesBoost Price TargetBuyC$14.00 ➝ C$16.00N/AView Rating Details
6/5/2017Wellington ShieldsDowngradeGradually Accumulate ➝ HoldLowView Rating Details
11/30/2016Goldman Sachs GroupInitiated CoverageNeutral$71.00N/AView Rating Details
11/4/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
(Data available from 5/25/2016 forward)

Earnings

STERIS (NYSE:STE) Earnings History and Estimates Chart

Earnings by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Earnings Estimates

2018 EPS Consensus Estimate: $4.05
2019 EPS Consensus Estimate: $4.74
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.80$0.82$0.81
Q2 20182$0.92$0.94$0.93
Q3 20182$1.06$1.11$1.09
Q4 20182$1.22$1.22$1.22
Q1 20192$0.96$0.99$0.98
Q2 20192$1.07$1.12$1.10
Q3 20192$1.24$1.28$1.26
Q4 20192$1.39$1.42$1.41

STERIS (NYSE STE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/6/2018$0.99N/AView Earnings Details
5/9/2018Q4 2018$1.22$1.24$703.37 million$716.00 millionViewListenView Earnings Details
2/7/2018Q3 2018$1.07$1.12$663.17 million$661.90 millionViewN/AView Earnings Details
11/1/2017Q2 2018$0.95$0.94$629.02 million$634.20 millionViewN/AView Earnings Details
8/8/2017Q1 2018$0.80$0.85$597.66 million$608.00 millionViewListenView Earnings Details
5/9/2017Q4$1.07$1.11$673.47 million$681.20 millionViewListenView Earnings Details
2/7/2017Q317$1.04$0.98$680.13 million$646.80 millionViewListenView Earnings Details
11/2/2016Q217$0.90$0.89$670.24 million$646.40 millionViewN/AView Earnings Details
8/9/2016Q117$0.77$0.79$639.04 million$638.40 millionViewListenView Earnings Details
5/18/2016Q416$1.04$0.90$701.92 million$690.30 millionViewListenView Earnings Details
2/9/2016Q316$0.94$0.98$617.35 million$618.70 millionViewN/AView Earnings Details
10/30/2015Q216$0.76$0.83$488.66 million$489.90 millionViewListenView Earnings Details
8/4/2015Q415$0.61$0.62$439.23 million$439.90 millionViewListenView Earnings Details
5/7/2015Q4$0.89$0.98$520.07 million$501.60 millionViewListenView Earnings Details
2/4/2015Q315$0.73$0.79$475.22 million$473.20 millionViewListenView Earnings Details
11/4/2014Q215$0.62$0.68$452.50 million$462.70 millionViewListenView Earnings Details
8/5/2014Q115$0.54$0.54$418.26 million$412.60 millionViewListenView Earnings Details
5/8/2014Q4$0.86$0.91$455.92 million$465.30 millionViewListenView Earnings Details
2/5/2014Q314$0.69$0.59$406.40 million$405.60 millionViewListenView Earnings Details
10/30/2013Q214$0.54$0.55$376.82 million$383.80 millionViewListenView Earnings Details
8/7/2013Q1 2014$0.56$0.44$372.69 million$367.70 millionViewListenView Earnings Details
5/7/2013Q4 2013$0.65$0.70$405.79 million$426.20 millionViewListenView Earnings Details
2/6/2013Q3 2013$0.56$0.58$368.84 million$380.40 millionViewListenView Earnings Details
10/31/2012Q213$0.52$0.53$350.23 million$356.30 millionViewN/AView Earnings Details
8/2/2012$0.44$0.53ViewN/AView Earnings Details
5/8/2012$0.60$0.59ViewN/AView Earnings Details
2/7/2012$0.60$0.58ViewN/AView Earnings Details
11/2/2011$0.57$0.50ViewN/AView Earnings Details
8/2/2011$0.50$0.46ViewN/AView Earnings Details
5/9/2011$0.62$0.61ViewN/AView Earnings Details
2/8/2011$0.58$0.57ViewN/AView Earnings Details
11/3/2010Q2 2011$0.54$0.55ViewN/AView Earnings Details
8/3/2010Q1 2011$0.45$0.46ViewN/AView Earnings Details
5/6/2010Q4 2010$0.53$0.55ViewN/AView Earnings Details
2/2/2010Q3 2010$0.47$0.69ViewN/AView Earnings Details
11/3/2009Q2 2010$0.43$0.54ViewN/AView Earnings Details
7/30/2009Q1 2010$0.41$0.43ViewN/AView Earnings Details
5/7/2009Q4 2009$0.38$0.49ViewN/AView Earnings Details
1/27/2009Q3 2009$0.37$0.53ViewN/AView Earnings Details
10/30/2008Q2 2009$0.34$0.48ViewN/AView Earnings Details
7/30/2008Q1 2009$0.27$0.43ViewN/AView Earnings Details
5/7/2008Q4 2008$0.50$0.59ViewN/AView Earnings Details
1/30/2008Q3 2008$0.38$0.35ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

STERIS (NYSE:STE) Dividend Information

STERIS pays an annual dividend of $1.24 per share, with a dividend yield of 1.19%. STE's next quarterly dividend payment will be made on Thursday, June 28. The company has grown its dividend for the last 8 consecutive years and is increasing its dividend by an average of 10.30% each year. STERIS pays out 29.88% of its earnings out as a dividend.
Next Dividend:6/28/2018
Annual Dividend:$1.24
Dividend Yield:1.19%
Dividend Growth:10.30% (3 Year Average)
Payout Ratio(s):29.88% (Trailing 12 Months of Earnings)
26.33% (Based on This Year's Estimates)
24.03% (Based on Next Year's Estimates)
22.90% (Based on Cash Flow)
Track Record:8 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/11/2018quarterly$0.311.2%6/7/20186/8/20186/28/2018
2/7/2018quarterly$0.311.35%2/27/20182/28/20183/28/2018
11/1/2017Quarterly$0.311.42%11/21/201711/22/201712/20/2017
8/8/2017Quarterly$0.311.46%8/25/20178/29/20179/28/2017
5/9/2017Quarterly$0.286/5/20176/7/20176/29/2017
2/7/2017Quarterly$0.281.67%2/24/20172/28/20173/28/2017
11/2/2016Quarterly$0.281.69%11/21/201611/23/201612/21/2016
8/9/2016Quarterly$0.281.6%8/26/20168/30/20169/27/2016
5/18/2016quarterly$0.251.43%6/6/20166/8/20166/29/2016
2/9/2016Quarterly$0.252/26/20163/1/20163/29/2016
10/19/2015quarterly$0.251.45%10/28/201510/30/201512/18/2015
8/5/2015quarterly$0.251.45%8/21/20158/25/20159/22/2015
5/7/2015quarterly$0.231.35%6/1/20156/3/20156/25/2015
2/5/2015quarterly$0.231.36%2/23/20152/25/20153/25/2015
11/5/2014quarterly$0.231.47%11/24/201411/26/201412/23/2014
8/6/2014quarterly$0.231.79%8/22/20148/26/20149/23/2014
5/14/2014quarterly$0.211.58%6/3/20146/5/20146/26/2014
2/6/2014quarterly$0.211.91%2/24/20142/26/20143/26/2014
10/30/2013$0.2111/18/201311/20/201312/18/2013
8/7/2013quarterly$0.211.91%8/26/20138/28/20139/25/2013
5/8/2013quarterly$0.191.69%5/31/20136/4/20136/25/2013
2/7/2013quarterly$0.191.93%2/25/20132/27/20133/27/2013
(Data available from 1/1/2013 forward)

Insider Trades

STERIS (NYSE STE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.55%
Institutional Ownership Percentage: 91.03%
Insider Trading History for STERIS (NYSE:STE)
Institutional Ownership by Quarter for STERIS (NYSE:STE)

STERIS (NYSE STE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2018Michael B WoodDirectorSell3,800$103.51$393,338.0022,331View SEC Filing  
5/15/2018Sudhir K PahwaVPSell2,000$102.12$204,240.00View SEC Filing  
5/11/2018Karen L. BurtonVPSell1,204$102.74$123,698.96View SEC Filing  
5/11/2018Loyal W WilsonDirectorSell2,744$103.29$283,427.7629,240View SEC Filing  
5/9/2018Michael B WoodDirectorSell2,744$100.00$274,400.00View SEC Filing  
5/9/2018Walter M Rosebrough JrCEOSell10,000$100.50$1,005,000.00View SEC Filing  
4/23/2018Sudhir K. PahwaVPSell19$97.00$1,843.00View SEC Filing  
4/18/2018Sudhir K. PahwaVPSell1,981$97.11$192,374.91View SEC Filing  
3/12/2018Walter M Rosebrough JrCEOSell10,000$95.50$955,000.00View SEC Filing  
3/5/2018Richard Martin SteevesDirectorSell58,953$91.00$5,364,723.009,362View SEC Filing  
2/28/2018Jacqueline B KosecoffDirectorSell2,744$91.94$252,283.36View SEC Filing  
2/26/2018Cynthia L FeldmannDirectorSell3,218$91.35$293,964.3011,214View SEC Filing  
2/13/2018Karen L BurtonVPSell1,500$85.59$128,385.00View SEC Filing  
1/29/2018Sudhir K. PahwaVPSell2,000$92.09$184,180.00View SEC Filing  
11/14/2017John Adam ZangerleVPSell3,650$88.00$321,200.00View SEC Filing  
10/23/2017Michael J TokichInsiderSell11,000$92.00$1,012,000.0058,588View SEC Filing  
10/4/2017Michael J TokichInsiderSell12,000$89.75$1,077,000.00View SEC Filing  
10/4/2017Walter M Rosebrough JrCEOSell10,000$90.50$905,000.00View SEC Filing  
9/8/2017Richard Martin SteevesDirectorSell156,072$87.13$13,598,553.369,362View SEC Filing  
8/16/2017Walter M Rosebrough JrCEOSell10,000$85.69$856,900.0083,270View SEC Filing  
8/15/2017Karen L BurtonVPSell3,270$85.70$280,239.0011,807View SEC Filing  
8/9/2017Mohsen SohiDirectorSell2,744$85.98$235,929.1221,816View SEC Filing  
7/3/2017Michael B WoodDirectorSell4,000$81.50$326,000.0026,131View SEC Filing  
6/16/2017Kathleen BardwellInsiderSell3,795$82.00$311,190.0020,605View SEC Filing  
6/13/2017Daniel A. CarestioInsiderSell4,745$80.08$379,979.60View SEC Filing  
6/2/2017Walter M. Rosebrough, Jr.CEOSell10,000$80.05$800,500.00View SEC Filing  
6/1/2017Kathleen BardwellInsiderSell4,000$79.00$316,000.0020,975View SEC Filing  
6/1/2017Sudhir K PahwaVPSell3,000$79.07$237,210.0022,047View SEC Filing  
5/25/2017Sudhir K. PahwaVPSell800$77.28$61,824.00View SEC Filing  
5/9/2017Michael J TokichCFOSell13,600$76.00$1,033,600.0058,106View SEC Filing  
5/9/2017Sudhir K. PahwaVPSell200$77.00$15,400.00View SEC Filing  
5/3/2017Daniel A CarestioInsiderSell7,590$75.17$570,540.3025,390View SEC Filing  
5/3/2017John Adam ZangerleVPSell3,150$75.00$236,250.0026,639View SEC Filing  
5/3/2017Michael B WoodDirectorSell4,000$75.00$300,000.0030,131View SEC Filing  
5/3/2017Michael J TokichCFOSell2,000$75.00$150,000.0046,506View SEC Filing  
2/13/2017Mohsen SohiDirectorSell3,387$67.66$229,164.4224,421View SEC Filing  
1/17/2017Kathleen BardwellInsiderSell1,962$68.78$134,946.3616,538View SEC Filing  
12/13/2016John Adam ZangerleVPSell3,100$69.00$213,900.0026,589View SEC Filing  
12/8/2016Daniel A CarestioInsiderSell2,225$67.54$150,276.5020,025View SEC Filing  
11/15/2016John Adam ZangerleVPSell2,200$67.00$147,400.0026,166View SEC Filing  
11/4/2016Cynthia L FeldmannDirectorSell4,744$64.98$308,265.1214,581View SEC Filing  
9/7/2016Richard Martin SteevesDirectorSell204,778$71.19$14,578,145.82165,434View SEC Filing  
8/31/2016Adrian Vincent CowardInsiderSell15,000$69.00$1,035,000.00View SEC Filing  
8/26/2016Sudhir K. PahwaVPSell1,028$70.13$72,093.64View SEC Filing  
8/17/2016Walter M. Rosebrough, Jr.CEOSell15,000$71.08$1,066,200.00View SEC Filing  
8/12/2016Daniel A. CarestioInsiderSell2,681$71.04$190,458.24View SEC Filing  
2/17/2016Walter M. Rosebrough, Jr.CEOSell10,000$64.27$642,700.00View SEC Filing  
11/18/2015Walter M Rosebrough JrCEOSell11,960$75.58$903,936.80111,376View SEC Filing  
11/9/2015Kathleen BardwellinsiderSell2,496$73.85$184,329.6013,235View SEC Filing  
11/9/2015Kevin M. McmullenDirectorSell8,000$73.73$589,840.0026,338View SEC Filing  
11/3/2015Mohsen SohiDirectorSell3,000$76.36$229,080.0020,250View SEC Filing  
10/30/2015Daniel A. CarestioinsiderSell6,270$74.00$463,980.0016,800View SEC Filing  
10/28/2015Sudhir K PahwaVPSell1,000$70.09$70,090.0021,289View SEC Filing  
9/30/2015Walter M Rosebrough JrCEOSell5,000$64.92$324,600.00116,376View SEC Filing  
9/29/2015Walter M Rosebrough JrCEOSell10,000$64.43$644,300.00121,376View SEC Filing  
6/15/2015David Allen JohnsonVPSell1,826$63.08$115,184.08View SEC Filing  
6/10/2015Walter M Rosebrough JrCEOSell20,000$63.80$1,276,000.00View SEC Filing  
6/9/2015Walter M Rosebrough JrCEOSell5,000$63.56$317,800.00View SEC Filing  
8/11/2014Michael B WoodDirectorSell5,300$51.79$274,487.00View SEC Filing  
6/2/2014John Adam ZangerleVPSell2,000$53.45$106,900.00View SEC Filing  
5/12/2014John WarehamDirectorSell15,000$55.09$826,350.0023,256View SEC Filing  
4/2/2014Michael TokichCFOSell4,525$51.68$233,852.0030,320View SEC Filing  
1/8/2014Michael TokichCFOSell4,200$48.72$204,624.0030,320View SEC Filing  
11/26/2013Cynthia FeldmannDirectorSell6,254$45.97$287,496.3810,000View SEC Filing  
8/8/2013Timothy ChapmanSVPSell10,000$43.84$438,400.0021,581View SEC Filing  
6/12/2013Kevin M McmullenDirectorSell10,000$44.09$440,900.00View SEC Filing  
5/30/2013Walter M Rosebrough JrCEOSell2,000$45.72$91,440.00View SEC Filing  
5/22/2013Mohsen SohiDirectorSell10,000$45.21$452,100.00View SEC Filing  
5/21/2013William L AamothTreasurerSell6,150$45.96$282,654.00View SEC Filing  
5/13/2013David Allen JohnsonVPSell2,680$44.99$120,573.20View SEC Filing  
10/5/2012Michael J TokichCFOSell4,100$37.00$151,700.00View SEC Filing  
8/9/2012Cynthia L FeldmannDirectorSell23,122$34.05$787,304.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

STERIS (NYSE STE) News Headlines

Source:
DateHeadline
Medical Instruments Disinfections Market is Forecast to Cross US$ 5.0 Billion By 2024Medical Instruments Disinfections Market is Forecast to Cross US$ 5.0 Billion By 2024
www.marketwatch.com - May 24 at 4:47 PM
Global Sterilization Equipment Market Growth Opportunities: Matachana Group, STERIS Corporation, Belimed AGGlobal Sterilization Equipment Market Growth Opportunities: Matachana Group, STERIS Corporation, Belimed AG
www.marketwatch.com - May 24 at 9:07 AM
Michael B. Wood Sells 3,800 Shares of STERIS (STE) StockMichael B. Wood Sells 3,800 Shares of STERIS (STE) Stock
www.americanbankingnews.com - May 21 at 7:34 PM
Zacks: Analysts Anticipate STERIS (STE) Will Post Quarterly Sales of $640.43 MillionZacks: Analysts Anticipate STERIS (STE) Will Post Quarterly Sales of $640.43 Million
www.americanbankingnews.com - May 21 at 4:18 AM
Zacks: Brokerages Anticipate STERIS (STE) to Post $0.98 Earnings Per ShareZacks: Brokerages Anticipate STERIS (STE) to Post $0.98 Earnings Per Share
www.americanbankingnews.com - May 19 at 9:25 AM
Does STERIS plc’s (NYSE:STE) PE Ratio Signal A Buying Opportunity?Does STERIS plc’s (NYSE:STE) PE Ratio Signal A Buying Opportunity?
finance.yahoo.com - May 18 at 4:54 PM
Endoscope Reprocessing Market is Determined to Cross US$ 2.0 Billion By 2022Endoscope Reprocessing Market is Determined to Cross US$ 2.0 Billion By 2022
www.marketwatch.com - May 17 at 5:13 PM
Infection Control Market is Determined to Cross US$ 18 Billion By 2024Infection Control Market is Determined to Cross US$ 18 Billion By 2024
www.marketwatch.com - May 17 at 5:13 PM
STERIS (STE) VP Sells $204,240.00 in StockSTERIS (STE) VP Sells $204,240.00 in Stock
www.americanbankingnews.com - May 16 at 8:16 PM
Head-To-Head Analysis: Consort Medical (CSRMY) vs. STERIS (STE)Head-To-Head Analysis: Consort Medical (CSRMY) vs. STERIS (STE)
www.americanbankingnews.com - May 16 at 1:29 PM
STERIS (STE) Director Sells $283,427.76 in StockSTERIS (STE) Director Sells $283,427.76 in Stock
www.americanbankingnews.com - May 14 at 7:59 PM
STERIS (STE) VP Sells $123,698.96 in StockSTERIS (STE) VP Sells $123,698.96 in Stock
www.americanbankingnews.com - May 14 at 7:58 PM
STERIS plcSTERIS plc
www.streetinsider.com - May 13 at 9:33 AM
STERIS (STE) Rating Increased to Buy at Zacks Investment ResearchSTERIS (STE) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 11 at 8:29 PM
STERIS (STE) Declares Quarterly Dividend of $0.31STERIS (STE) Declares Quarterly Dividend of $0.31
www.americanbankingnews.com - May 11 at 5:45 PM
STERIS (STE) Forecasted to Post Q1 2019 Earnings of $0.96 Per ShareSTERIS (STE) Forecasted to Post Q1 2019 Earnings of $0.96 Per Share
www.americanbankingnews.com - May 11 at 10:57 AM
STERIS (STE) Director Sells $274,400.00 in StockSTERIS (STE) Director Sells $274,400.00 in Stock
www.americanbankingnews.com - May 10 at 7:53 PM
STERIS (STE) CEO Walter M. Rosebrough, Jr. Sells 10,000 SharesSTERIS (STE) CEO Walter M. Rosebrough, Jr. Sells 10,000 Shares
www.americanbankingnews.com - May 10 at 7:37 PM
STERIS (STE) Q4 Earnings & Revenues Beat Estimates, Up Y/YSTERIS (STE) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
www.zacks.com - May 10 at 9:24 AM
Edited Transcript of STE earnings conference call or presentation 9-May-18 2:00pm GMTEdited Transcript of STE earnings conference call or presentation 9-May-18 2:00pm GMT
finance.yahoo.com - May 10 at 9:24 AM
STERIS (STE) Announces Quarterly  Earnings ResultsSTERIS (STE) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 9 at 5:55 PM
STERIS Plc (STE) Q4 2018 Results - Earnings Call TranscriptSTERIS Plc (STE) Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 4:45 PM
STERIS (STE) Releases FY19 Earnings GuidanceSTERIS (STE) Releases FY19 Earnings Guidance
www.americanbankingnews.com - May 9 at 9:47 AM
Steris: Fiscal 4Q Earnings SnapshotSteris: Fiscal 4Q Earnings Snapshot
www.cnbc.com - May 9 at 9:15 AM
Steris beats by $0.02, beats on revenueSteris beats by $0.02, beats on revenue
seekingalpha.com - May 9 at 9:15 AM
STERIS Announces Financial Results for Fiscal 2018 Fourth Quarter and Full YearSTERIS Announces Financial Results for Fiscal 2018 Fourth Quarter and Full Year
finance.yahoo.com - May 9 at 9:15 AM
BRIEF-Steris Reports Q4 Earnings Per Share Of $0.86BRIEF-Steris Reports Q4 Earnings Per Share Of $0.86
www.reuters.com - May 9 at 9:15 AM
STERIS Announces Changes to Board of DirectorsSTERIS Announces Changes to Board of Directors
finance.yahoo.com - May 9 at 9:15 AM
Factors of Influence in 2018, Key Indicators and Opportunity within Sonic ...Factors of Influence in 2018, Key Indicators and Opportunity within Sonic ...
globenewswire.com - May 3 at 4:38 PM
STERIS (STE) and William Demant (WILYY) Financial ContrastSTERIS (STE) and William Demant (WILYY) Financial Contrast
www.americanbankingnews.com - May 3 at 11:17 AM
STERIS (STE) Expected to Announce Quarterly Sales of $709.63 MillionSTERIS (STE) Expected to Announce Quarterly Sales of $709.63 Million
www.americanbankingnews.com - May 3 at 2:30 AM
STERIS (STE) Given Consensus Rating of "Buy" by AnalystsSTERIS (STE) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 2 at 1:42 AM
STERIS (STE) Scheduled to Post Earnings on WednesdaySTERIS (STE) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - May 2 at 1:26 AM
$1.22 Earnings Per Share Expected for STERIS (STE) This Quarter$1.22 Earnings Per Share Expected for STERIS (STE) This Quarter
www.americanbankingnews.com - May 1 at 7:14 PM
STERIS (STE) Rating Lowered to Hold at Zacks Investment ResearchSTERIS (STE) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - May 1 at 12:26 PM
STERIS to Announce Fiscal 2018 Fourth Quarter and Full Year Financial Results on May 9, 2018STERIS to Announce Fiscal 2018 Fourth Quarter and Full Year Financial Results on May 9, 2018
finance.yahoo.com - April 25 at 4:49 PM
Varex Imaging Names Rosebrough To Board Of DirectorsVarex Imaging Names Rosebrough To Board Of Directors
finance.yahoo.com - April 23 at 8:56 AM
STERIS (STE) VP Sudhir K. Pahwa Sells 1,981 SharesSTERIS (STE) VP Sudhir K. Pahwa Sells 1,981 Shares
www.americanbankingnews.com - April 19 at 7:35 PM
STERIS (STE) Expected to Post Quarterly Sales of $709.63 MillionSTERIS (STE) Expected to Post Quarterly Sales of $709.63 Million
www.americanbankingnews.com - April 16 at 2:17 AM
BidaskClub Downgrades STERIS (STE) to BuyBidaskClub Downgrades STERIS (STE) to Buy
www.americanbankingnews.com - April 14 at 9:13 PM
$1.22 EPS Expected for STERIS (STE) This Quarter$1.22 EPS Expected for STERIS (STE) This Quarter
www.americanbankingnews.com - April 14 at 7:18 PM
Medical Instrument Stocks Head-to-Head: Abiomed vs. STERISMedical Instrument Stocks Head-to-Head: Abiomed vs. STERIS
finance.yahoo.com - April 13 at 9:29 AM
STERIS (STE) Downgraded to "Hold" at Zacks Investment ResearchSTERIS (STE) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 11:12 AM
Steris PLC (STE) Receives Consensus Recommendation of "Buy" from BrokeragesSteris PLC (STE) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 7 at 1:29 AM
KeyCorp Reaffirms "Buy" Rating for Steris (STE)KeyCorp Reaffirms "Buy" Rating for Steris (STE)
www.americanbankingnews.com - April 6 at 9:16 PM
Steris (STE) Rating Reiterated by KeyCorpSteris (STE) Rating Reiterated by KeyCorp
www.americanbankingnews.com - April 2 at 8:20 AM
Steris PLC (STE) Expected to Announce Quarterly Sales of $709.63 MillionSteris PLC (STE) Expected to Announce Quarterly Sales of $709.63 Million
www.americanbankingnews.com - March 30 at 1:50 AM
$1.22 EPS Expected for Steris PLC (STE) This Quarter$1.22 EPS Expected for Steris PLC (STE) This Quarter
www.americanbankingnews.com - March 28 at 11:12 PM
Steris (STE) Downgraded by Zacks Investment Research to "Hold"Steris (STE) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - March 28 at 2:41 PM
Steris (STE) Raised to "Buy" at Zacks Investment ResearchSteris (STE) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 27 at 2:54 PM

SEC Filings

STERIS (NYSE:STE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

STERIS (NYSE:STE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

STERIS (NYSE STE) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.